Science
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity
One adverse event was reported but was unrelated to the vaccine
Covishield not to be taken by those allergic to its ingredients: Serum Institute
A total of 580 adverse events were reported following immunisation for COVID-19 in the country till 5 pm on Monday
World's oldest known cave painting found in Indonesia
The painting is a life-sized picture of a wild pig that was made at least 45,500 years ago
Despite vaccines, no Covid herd immunity in 2021: WHO
Chief scientist Soumya Swaminathan warned that it will take time to produce and administer enough doses to halt the spread of the virus
Decreasing trend in black carbon Aerosol concentrations
Aerosols, the tiny particles suspended in the atmosphere, affect life through adverse health effects and have an enormous impact on climate
Pfizer vaccine may protect against new mutations of coronavirus
Owing to the evolution of the coronavirus, scientists have called for the continuous monitoring of changes in the virus for vaccine coverage
Covaxin: Last word on efficacy yet to be heard
Doubts raised over clinical trial mode as to why vaccine given permission without completion of human trials
Vaccine makers call approval a giant leap
SII has stockpiled around 5 crore dosages of the vaccine and aims to produce up to 10 crore per month by March next year
New coronavirus strain may replace the old one, say experts
The biggest worry is the status of the vaccines due to the emerging new strains
Bharat Biotech sends Phase-2 study results of Covaxin trial
Altogether, the data of human trials on 26,000 volunteers has to be submitted by the company to the subject committee